Literature DB >> 11716158

Endocrine complications of thalassemia.

D Tiosano1, Z Hochberg.   

Abstract

Growth, sexual development, fertility, bone mineral density, diabetes mellitus, hypothyroidism, hypoparathyroidism, and hypoadrenalism are the main issues to be addressed in the long-term follow-up of patients with thalassemia. During childhood, growth may be affected by anemia, and other potential endocrine complications. Puberty is the stage of the maximal growth insult. Beta thalassemia is associated with bone abnormalities characterized by bone marrow expansion of the medullary cavity, and osteopenia with cortical thickening and trabecular coarsening. Good nutrition with adequate vitamins and trace elements intake, along with calcium and vitamin D supplementation, can increase bone density and prevent bone loss. Endocrine abnormalities should be monitored carefully and a thorough endocrine evaluation should be carried out yearly in every patients to detect subclinical endocrinopaties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716158     DOI: 10.1007/BF03343916

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  49 in total

1.  A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.

Authors:  M Cazzola; C Borgna-Pignatti; F Locatelli; L Ponchio; Y Beguin; P De Stefano
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

2.  High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.

Authors:  S Mariotti; A Loviselli; S Murenu; F Sau; L Valentino; A Mandas; S Vacquer; E Martino; A Balestrieri; M E Lai
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

3.  Growth failure and bony changes induced by deferoxamine.

Authors:  N F Olivieri; G Koren; J Harris; S Khattak; M H Freedman; D M Templeton; J D Bailey; B J Reilly
Journal:  Am J Pediatr Hematol Oncol       Date:  1992

4.  Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. Evidence for dissociation of cortisol and adrenal androgen secretion.

Authors:  C A Sklar; L Q Lew; D J Yoon; R David
Journal:  Am J Dis Child       Date:  1987-03

5.  Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect.

Authors:  J Leger; R Girot; H Crosnier; M C Postel-Vinay; R Rappaport
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

6.  Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study.

Authors:  C Bergeron; K Kovacs
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

7.  Factors determining glucose tolerance in patients with thalassemia major.

Authors:  K Dmochowski; D T Finegood; W Francombe; B Tyler; B Zinman
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

8.  Growth hormone treatment in short children with beta-thalassemia major.

Authors:  G Katzos; E Papakostantinou-Athanasiadou; M Athanasiou-Metaxa; F Harsoulis
Journal:  J Pediatr Endocrinol Metab       Date:  2000-02       Impact factor: 1.634

9.  Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.

Authors: 
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

10.  Growth and endocrine function following bone marrow transplantation for thalassemia.

Authors:  M De Simone; P Olioso; P Di Bartolomeo; G Di Girolamo; G Farello; M Palumbo; G Papalinetti; P Bavaro; F Angrilli; G Torlontano
Journal:  Bone Marrow Transplant       Date:  1995-02       Impact factor: 5.483

View more
  12 in total

1.  Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study.

Authors:  Maria I Argyropoulou; Dimitrios N Kiortsis; Loukas Astrakas; Zafiria Metafratzi; Nikolaos Chalissos; Stavros C Efremidis
Journal:  Eur Radiol       Date:  2007-06-05       Impact factor: 5.315

2.  Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy.

Authors:  A Masala; M M Atzeni; S Alagna; D Gallisai; C Burrai; M G Mela; P P Rovasio; P Gallo
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

3.  Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.

Authors:  Somchit Jaruratanasirikul; Rarong Chareonmuang; Malai Wongcharnchailert; Vichai Laosombat; Pasuree Sangsupavanich; Kalaya Leetanaporn
Journal:  Eur J Pediatr       Date:  2007-09-25       Impact factor: 3.183

Review 4.  Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.

Authors:  Kornkamon Lertsuwan; Kannikar Wongdee; Jarinthorn Teerapornpuntakit; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2018-02-26       Impact factor: 2.781

5.  Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.

Authors:  Massimo Scacchi; Leila Danesi; Agnese Cattaneo; Giovanna Sciortino; Raffaella Radin; Alberto Giacinto Ambrogio; Giovanni Vitale; Emanuela D'Angelo; Nadia Mirra; Laura Zanaboni; Marica Arvigo; Mara Boschetti; Diego Ferone; Paolo Marzullo; Marina Baldini; Elena Cassinerio; Maria Domenica Cappellini; Luca Persani; Francesco Cavagnini
Journal:  Endocrine       Date:  2016-01-29       Impact factor: 3.633

6.  Thalassaemia and aberrations of growth and puberty.

Authors:  Andreas Kyriakou; Nicos Skordis
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-27       Impact factor: 2.576

7.  Association between levels of serum ferritin and bone mineral density in Korean premenopausal and postmenopausal women: KNHANES 2008-2010.

Authors:  Seung Joo Chon; Yun Rak Choi; Yun Ho Roh; Bo Hyon Yun; SiHyun Cho; Young Sik Choi; Byung Seok Lee; Seok Kyo Seo
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

8.  The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.

Authors:  İlkay S İdilman; Fatma Gümrük; Mithat Haliloğlu; Muşturay Karçaaltıncaba
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

Review 9.  Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Alice Albu; Soad Al Jaouni; Salvatore Anastasi; Maria Grazia Bisconte; Duran Canatan; Soteroula Christou; Shahina Daar; Salvatore Di Maio; Mohamed El Kholy; Doaa Khater; Mohamed Elshinawy; Yurdanur Kilinc; Roberto Mattei; Hala H Mosli; Alessandra Quota; Maria Grazia Roberti; Praveen Sobti; Saif Al Yaarubi; Saveria Canpisi; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

Review 10.  Ineffective erythropoiesis in β -thalassemia.

Authors:  Jean-Antoine Ribeil; Jean-Benoit Arlet; Michael Dussiot; Ivan Cruz Moura; Geneviève Courtois; Olivier Hermine
Journal:  ScientificWorldJournal       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.